58885-92-0 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(1-Aminocyclopentyl)acetic acid is utilized as a key building block in the synthesis of bioactive compounds and pharmaceuticals, specifically for the development of drug candidates targeting conditions such as pain and inflammation. Its unique structure and functional groups contribute to the creation of novel therapeutic agents with potential efficacy in managing these health issues.
Used in the Synthesis of Novel Chemical Entities:
In the field of medicinal chemistry, (1-Aminocyclopentyl)acetic acid serves as a precursor for the synthesis of innovative chemical entities. These newly synthesized compounds may possess untapped therapeutic potential, expanding the range of available treatments for various medical conditions.
Used in Preclinical Studies:
(1-Aminocyclopentyl)acetic acid is employed in preclinical studies to evaluate the safety, efficacy, and pharmacological properties of newly synthesized compounds. This helps in the assessment of their potential as viable drug candidates before they proceed to clinical trials.
Used in Chemical Synthesis Education:
As a component of organic chemistry curricula, (1-Aminocyclopentyl)acetic acid can be used to illustrate the synthesis of complex organic molecules, providing students with hands-on experience in the preparation of bioactive compounds and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 58885-92-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,8,8 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 58885-92:
(7*5)+(6*8)+(5*8)+(4*8)+(3*5)+(2*9)+(1*2)=190
190 % 10 = 0
So 58885-92-0 is a valid CAS Registry Number.
58885-92-0Relevant academic research and scientific papers
N-SUBSTITUTED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT
-
, (2008/06/13)
The invention relates to N-substituted heterocyclic derivatives and its salts. These derivatives have the formula (I) in which the substituents are as defined in the specification. Application: Angiotensin II antagonists
